Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial

Breast Cancer Research and Treatment

Volumn 158, Issue 3, 2016, Pages 497-507

  Adams, Scott C ^a   Segal, Roanne J ^b   McKenzie, Donald C ^c   Vallerand, James R ^a   Morielli, Andria R ^a   Mackey, John R ^d   Gelmon, Karen ^e   Friedenreich, Christine M ^f   Reid, Robert D ^g   Courneya, Kerry S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CROSS CANCER INSTITUTE   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f ALBERTA HEALTH SERVICES   (Canada)

^g UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Body composition; Muscle dysfunction; Quality of life; Resistance exercise; Skeletal muscle index

Indexed keywords

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CONTROLLED STUDY; DYNAPENIA; EARLY CANCER; EXPLORATORY RESEARCH; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ANEMIA SCALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY FATIGUE SUBSCALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY TRIAL OUTCOME INDEX ANEMIA SUBSCALE; HUMAN; INTERMETHOD COMPARISON; LOWER EXTREMITY MUSCLE DYSFUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); MUSCLE DISEASE; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; SARCOPENIA; SKELETAL MUSCLE INDEX; THERAPY EFFECT; UPPER EXTREMITY MUSCLE DYSFUNCTION; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CHEMICALLY INDUCED; CLINICAL TRIAL; EXERCISE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESISTANCE TRAINING; SARCOPENIA; TREATMENT OUTCOME;

EID: 84978140788     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3900-2     Document Type: Article

References (38)

1. Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. New Engl J Med 344(26):1997–2008. doi:10.1056/NEJM200106283442607
2. Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH, American Society of Clinical Oncology (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30(13):1553–1561. doi:10.1200/JCO.2011.39.9436
3. Griggs JJ, Sorbero ME, Lyman GH (2005) Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165(11):1267–1273. doi:10.1001/archinte.165.11.1267
4. Madarnas Y, Sawka CA, Franssen E, Bjarnason GA (2001) Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat 66(2):123–133
5. Kaidar-Person O, Bar-Sela G, Person B (2011) The two major epidemics of the twenty-first century: obesity and cancer. Obes Surg 21(11):1792–1797. doi:10.1007/s11695-011-0490-2
6. Parekh N, Chandran U, Bandera EV (2012) Obesity in cancer survival. Annu Rev Nutr 32:311–342. doi:10.1146/annurev-nutr-071811-150713
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New Engl J Med 348(17):1625–1638. doi:10.1056/NEJMoa021423
8. Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 4(4):486–501. doi:10.1158/1940-6207.CAPR-10-0229
9. James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI (2015) Obesity in breast cancer—what is the risk factor? Eur J Cancer 51(6):705–720. doi:10.1016/j.ejca.2015.01.057
10. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15(8):2920–2926. doi:10.1158/1078-0432.CCR-08-2242
11. Villaseñor A, Ballard-Barbash R, Baumgartner KB, Baumgartner RN, Bernstein L, McTiernan A, Neuhouser ML (2012) Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv 6(4):398–406
12. Dodson RM, Firoozmand A, Hyder O, Tacher V, Cosgrove DP, Bhagat N, Herman JM, Wolfgang CL, Geschwind J-FH, Kamel IR (2013) Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg 17(12):2123–2132
13. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629–635. doi:10.1016/S1470-2045(08)70153-0
14. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15(22):6973–6979. doi:10.1158/1078-0432.CCR-09-1525
15. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel J-P, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423. doi:10.1093/ageing/afq034
16. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68(9):1001–1007. doi:10.1038/ejcn.2014.117
17. Muller MJ, Geisler C, Pourhassan M, Gluer CC, Bosy-Westphal A (2014) Assessment and definition of lean body mass deficiency in the elderly. Eur J Clin Nutr 68(11):1220–1227. doi:10.1038/ejcn.2014.169
18. Courneya KS, Crawford JJ, Adams SC (2015) Physical activity and exercise interventions in cancer survivors. In: Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ, McCorkle R (eds) Psycho-oncology, 3rd edn. Oxford University Press, New York, pp 515–520
19. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064
20. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896. doi:10.1046/j.1532-5415.2002.50216.x
21. Heymsfield SB, Gallagher D, Mayer L, Beetsch J, Pietrobelli A (2007) Scaling of human body composition to stature: new insights into body mass index. Am J Clin Nutr 86(1):82–91
22. Jaric S (2002) Muscle strength testing. Sports Med 32(10):615–631
23. da Silva Alexandre T, De Oliveira Duarte YA, Ferreira Santos JL, Wong R, Lebrão ML (2014) Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging 18(8):751–756
24. Davies MJ, Dalsky GP (1997) Normalizing strength for body size differences in older adults. Med Sci Sports Exerc 29(5):713–717. doi:10.1097/00005768-199705000-00020
25. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, Yasui Y, McKenzie DC (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404. doi:10.1200/JCO.2006.08.2024
26. Cella D, Eton DT, Lai J, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24(6):547–561
27. Lander J (1985) Maximum based on reps. NSCA J 6:60–61
28. Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS One 4(9):e7038
29. Brown DA, Miller WC (1998) Normative data for strength and flexibility of women throughout life. Eur J Appl Physiol 78(1):77–82. doi:10.1007/s004210050390
30. Hollander DB, Kraemer RR, Kilpatrick MW, Ramadan ZG, Reeves GV, Francois M, Hebert EP, Tryniecki JL (2007) Maximal eccentric and concentric strength discrepancies between young men and women for dynamic resistance exercise. J Strength Cond Res 21(1):34–40
31. Clark BC, Manini TM (2008) Special article “Green Banana”—Sarcopenia not equal dynapenia. J Gerontol A Biol Sci Med Sci 63(8):829–834
32. Baumgartner RN (2000) Body composition in healthy aging. Ann N Y Acad Sci 904(1):437–448
33. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS (2001) Sarcopenia. J Lab Clin Med 137(4):231–243. doi:10.1067/mlc.2001.113504
34. da Silva Alexandre T, De Oliveira Duarte YA, Ferreira Santos JL, Wong R, Lebrão ML (2014) Sarcopenia according to the European Working Group on Sarcopenia in older people (EWGSOP) versus dynapenia as a risk factor for disability in the elderly. J Nutr Health Aging 18(5):547–553. doi:10.1007/s12603-014-0465-9
35. Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Crawford JJ, Mackey JR (2014) Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc 46(9):1744–1751
36. Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, Sjostrom M, Blair SN (2008) Association between muscular strength and mortality in men: prospective cohort study. BMJ 337:a439. doi:10.1136/bmj.a439
37. Ruiz JR, Sui XM, Lobelo F, Lee DC, Morrow JR, Jackson AW, Hebert JR, Matthews CE, Sjostrom M, Blair SN (2009) Muscular strength and adiposity as predictors of adulthood cancer mortality in men. Cancer Epidemiol Biomarkers Prev 18(5):1468–1476. doi:10.1158/1055-9965.EPI-08-1075
38. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, Morley JE (2007) Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10(4):433–442. doi:10.1097/MCO.0b013e3281a30594